shareholder rights

REGENXBIO faces securities fraud lawsuit for allegedly making false statements about RGX-111 safety while withholding adverse trial data from investors between February 2022 and January 2026.

Schall Law Firm recruits lead plaintiffs for MCTA securities fraud class action lawsuit stemming from alleged undisclosed promotion scheme and SEC trading suspension.

Law firm Halper Sadeh investigates four major corporate transactions for potential fiduciary duty breaches, examining whether shareholders receive fair treatment and deal structures limit competitive bidding.

Class action lawsuit filed against Picard Medical for alleged securities fraud involving false statements and share price manipulation during fall 2025. Investors who purchased shares during this period may be eligible for damages.

Paysafe faces securities fraud lawsuit for allegedly making false statements about client risk exposure and understating credit loss reserves during March-November 2025.

Schall Law Firm recruits lead plaintiffs for securities fraud class action against Masonite, alleging false statements and improper share buybacks during June 2023-February 2024.

Schall Law Firm sues Ramaco Resources for allegedly making false statements about Brook Mine operations, affecting investors who purchased stock between July-October 2025.

Schall Law Firm launches class action against Beyond Meat for allegedly issuing false statements about asset valuations, affecting shareholders from February-November 2025.

Class action lawsuit filed against Ardent Health for allegedly misrepresenting accounting practices and collection methodologies to investors between July 2024 and November 2025.

Beyond Meat faces shareholder class action over alleged undisclosed asset impairment charges. Investors who bought stock Feb-Nov 2025 can join litigation by March 24, 2026.

Schall Law Firm launches class action against Charming Medical (MCTA) after SEC suspended trading following alleged market manipulation through social media promotion.